69 ms·
Taking psychedelics in a therapy setting is even more risky than off-label prescription itself. The patient may think there is little risk but there is a chance
by ketamine__ 7y ago
Taking psychedelics in a therapy setting is even more risky than off-label prescription itself. The patient may think there is little risk but there is a chance of making the condition worse.
- pas 7y agoSources? Data? Evidence? Studies? Citations please. This is a very strong claim! And I'm saying this because my gut feeling sort of agrees with you, but so far MAPS' FDA approved studies doesn't seem indicate that there's this risk factor. Who knows what will happen if it hits mainstream though. (As with any other therapies, at first everything is magical, because truly motivated people practice them, then it just becomes something done by certified professionals, then it just becomes a big section in a regular textbook.) That said, there is very good chance that even if it's risky, it has at least the potential to do real work. ( https://slatestarcodex.com/2019/11/26/mental-mountains/ https://slatestarcodex.com/2019/11/26/mental-mountains/ )
- ketamine__ 7y agoCommentary: https://www.mdedge.com/psychiatry/article/24216/depression/d-cycloserine-ptsd-proves-underwhelming https://www.mdedge.com/psychiatry/article/24216/depression/d... Paper: https://mdedge-files-live.s3.us-east-2.amazonaws.com/files/s3fs-public/issues/articles/70486_main_9.pdf https://mdedge-files-live.s3.us-east-2.amazonaws.com/files/s...